A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck.
about
Preclinical efficacy of Sym004, novel anti-EGFR antibody mixture, in esophageal squamous cell carcinoma cell lines.Targeting pathways mediating resistance to anti-EGFR therapy in squamous cell carcinoma of the head and neck.Systemic Treatment in HPV-Induced Recurrent or Metastatic HNSCC.Cardiotoxicity of ErbB2-targeted therapies and its impact on drug development, a spotlight on trastuzumab.Therapeutic efficacy of SYM004, a mixture of two anti-EGFR antibodies in human colorectal cancer with acquired resistance to cetuximab and MET activation.Phase I dose-escalation trial of Sym004, an anti-EGFR antibody mixture, in Japanese patients with advanced solid tumors
P2860
A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A proof of concept trial of th ...... arcinoma of the head and neck.
@en
type
label
A proof of concept trial of th ...... arcinoma of the head and neck.
@en
prefLabel
A proof of concept trial of th ...... arcinoma of the head and neck.
@en
P2093
P2860
P1476
A proof of concept trial of th ...... arcinoma of the head and neck.
@en
P2093
J-P Machiels
M-C Kaminsky
N J Skartved
P Pamperin
P Specenier
P2860
P2888
P356
10.1007/S00280-015-2761-4
P577
2015-05-08T00:00:00Z
P6179
1039200302